STAT+: The trade war hits pause, but the biotech doom loop carries on
Biotechs has been whipsawed by the Trump tariff retreat, but the roller coaster almost surely isn't over yet.
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox.
“Always you, with the bad news.” — King Henry VIII to Thomas Cromwell.
Biotechs whipsawed by Trump tariff retreat
Biotech stocks and the broader markets snapped higher Wednesday after President Trump announced a 90-day pause on reciprocal tariffs for all countries except China, backing down from a trade policy that had triggered a global macroeconomic crisis.
